Colorectal Neoplasia and Inflammatory Bowel Disease

Surgical Clinics of North America

Volumn 95, Issue 6, 2015, Pages 1261-1269

  Cannon, Jamie ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Colorectal cancer; Crohn's disease; Inflammatory bowel disease; Neoplasia; Ulcerative colitis

Indexed keywords

CANCER PREVENTION; CANCER RISK; COLONOSCOPY; COLORECTAL CANCER; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; HIGH RISK PATIENT; HUMAN; ILEOANAL ANASTOMOSIS; ILEUM POUCH; INFLAMMATORY BOWEL DISEASE; PRIORITY JOURNAL; PROCTOCOLECTOMY; REVIEW; RISK ASSESSMENT; ULCERATIVE COLITIS; COLITIS, ULCERATIVE; COLON RESECTION; COLORECTAL NEOPLASMS; COMPLICATION; PATHOLOGY;

COLECTOMY; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; CROHN DISEASE; HUMANS;

EID: 84951753806     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2015.08.001     Document Type: Review

References (42)

1. Eaden J.A., Abrams K.R., Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001, 48:526-535.
2. Harpaz N., Peck A.L., Yin J., et al. p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma. Hum Pathol 1994, 25:1069-1074.
3. Cohen R.D., Hanauer S.B. Surveillance colonoscopy in ulcerative colitis: is the message loud and clear. Am J Gastroenterol 1995, 90:2090-2092.
4. Rubin D.T., Huo D., Kinnucan J.A., et al. Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study. Clin Gastroenterol Hepatol 2013, 11(12):1601-1608.e1-4.
5. Lyakhovich A., Gasche C. Systematic review: molecular chemoprevention of colorectal malignancy by mesalazine. Aliment Pharmacol Ther 2010, 31:202-209.
6. Delaunoit T., Limburg P.J., Goldberg R.M., et al. Colorectal cancer prognosis among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2006, 4:335-342.
7. Kiran R., Khoury W., Church J., et al. Colorectal cancer complicating inflammatory bowel disease. Ann Surg 2010, 252:330-335.
8. Gearhart S.L., Nathan H., Pawlik T.M., et al. Outcomes from IBD-associated and non-IBD associated colorectal cancer: a surveillance epidemiology and end results medicare study. Dis Colon Rectum 2012, 55(3):270-277.
9. Jensen A., Larsen M., Gislum M., et al. Survival after colorectal cancer in patients with ulcerative colitis: a nationwide population-based Danish study. Am J Gastroenterol 2006, 101:1283-1287.
10. Herrinton L.J., Liu L., Levin T.R., et al. Incidence and in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology 2012, 143:382-389.
11. Efthymiou M., Taylor A.C., Kamm M.A. Cancer surveillance strategies in ulcerative colitis: the need for modernization. Inflamm Bowel Dis 2011, 17:1800-1813.
12. Bernstein C.N., Blanchard J.F., Kliewer E., et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 2001, 91:854-862.
13. Ekbom A., Helmick C., Zack M., et al. Ulcerative colitis and colorectal cancer: a population based study. N Engl J Med 1990, 323:1228-1233.
14. Choi C.H., Rutter M.D., Askari A., et al. Forty-year analysis of colonoscopic surveillance program for neoplasia in ulcerative colitis: an updated overview. Am J Gastroenterol 2015, 110(7):1022-1034.
15. Jess T., Simonsen J., Jorgensen K.T., et al. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology 2012, 143(2):375.
16. NCCN Guidelines Version 1. 2014 Colorectal Cancer Screening.
17. Lutgens M.W., van Oijen M.G., van der Heijden G.J., et al. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis 2013, 19:789-799.
18. Annese V., Daperno M., Rutter M.D., et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohn's Colitis 2013, 7:982-1018.
19. Mooiweer E., van der Meulen-de Jong A.E., Ponsioen C.Y., et al. Chromoendoscopy for surveillance in inflammatory bowel disease does not increase neoplasia detection compared with conventional colonoscopy with random biopsies: results from a large retrospective study. Am J Gastroenterol 2015, 110(7):1014-1021.
20. Bernstein C., Shanahan F., Weinstein W. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?. Lancet 1994, 343:71-75.
21. Nugent F.W., Haggitt R.C., Gilpin P.A. Cancer surveillance in ulcerative colitis. Gastroenterology 1991, 100(5 pt 1):1241-1248.
22. Kewenter J., Hultén L., Ahrén C. The occurrence of severe epithelial dysplasia and its bearing on treatment of longstanding ulcerative colitis. Ann Surg 1982, 195:209-213.
23. Fuson J.A., Farmer R.G., Hawk A., et al. Endoscopic surveillance for cancer in chronic ulcerative colitis. Am J Gastroenterol 1980, 73:120-126.
24. Lennard-Jones J.E., Morson B.C., Ritchie J.K., et al. Cancer in colitis: assessment of the individual risk by clinical and histological criteria. Gastroenterology 1977, 73:1280-1289.
25. Murphy J., Kalkbrenner K.A., Pemberton J.H., et al. Dysplasia in ulcerative colitis as a predictor of unsuspected synchronous colorectal cancer. Dis Colon Rectum 2014, 57(8):993-998.
26. Blackstone M.O., Riddell R.H., Rogers B.H., et al. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 1981, 80:366-374.
27. Lovegrove R.E., Constantinides V.A., Heriot A.G., et al. A comparison of hand-sewn versus stapled ileal pouch anal anastomosis (IPAA) following proctocolectomy: a meta-analysis of 4183 patients. Ann Surg 2006, 244:18-26.
28. Lavery I.C., Tuckson W.B., Easley K.A. Internal anal sphincter function after total abdominal colectomy and stapled ileal pouch-anal anastomosis without mucosal proctectomy. Dis Colon Rectum 1989, 32:950-953.
29. Silva-Velazco J., Stocchi L., Wu X.R., et al. Twenty-year-old stapled pouches for ulcerative colitis without evidence of rectal cancer: implications for surveillance strategy?. Dis Colon Rectum 2014, 57:1275-1281.
30. Um J.W., M'Koma A.E. Pouch-related dysplasia and adenocarcinoma following restorative proctocolectomy for ulcerative colitis. Tech Coloproctol 2011, 15:7-16.
31. Sequens R. Cancer in the anal canal (transitional zone) after restorative proctocolectomy with stapled ileal pouch-anal anastomosis. Int J Colorectal Dis 1997, 12:254-255.
32. Rotholtz N.A., Pikarsky A.J., Singh J.J., et al. Adenocarcinoma arising from along the rectal stump after double-stapled ileorectal J-pouch in a patient with ulcerative colitis: the need to perform a distal anastomosis. Report of a case. Dis Colon Rectum 2001, 44:1214-1217.
33. Scarpa M., van Koperen P.J., Ubbink D.T., et al. Systematic review of dysplasia after restorative proctocolectomy for ulcerative colitis. Br J Surg 2007, 94:534-545.
34. Kariv R., Remzi F.H., Lian L., et al. Preoperative colorectal neoplasia increases risk for pouch neoplasia in patients with restorative proctocolectomy. Gastroenterology 2010, 139:806-812.
35. Gillen C.D., Andrews H.A., Prior P., et al. Crohn's disease and colorectal cancer. Gut 1994, 35:651-655.
36. Jess T., Gamborg M., Matzen P., et al. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 2005, 100:2724-2729.
37. von Roon A.C., Reese G., Teare J., et al. The risk of cancer in patients with Crohn's disease. Dis Colon Rectum 2007, 50(6):839-855.
38. Devon K.M., Brown C.J., Burnstein M., et al. Cancer of the anus complicating perianal Crohn's disease. Dis Colon Rectum 2009, 52(2):211-216.
39. Wu X.R., Remzi F.H., Liu X.L., et al. Disease course and management strategy of pouch neoplasia in patients with underlying inflammatory bowel diseases. Inflamm Bowel Dis 2014, 20(11):2073-2082.
40. Rosenstock E., Farmer R.G., Petras R., et al. Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology 1985, 89:1342-1346.
41. von Herbay A., Herfarth C., Otto H.F. Cancer and dysplasia in ulcerative colitis: a histologic study of 301 surgical specimen. Z Gastroenterol 1994, 32:382-388.
42. Beaugerie L., Itzkowitz S.H. Cancers complicating inflammatory bowel disease. N Engl J Med 2015, 372(15):1441-1452.